Advertisement

Topics

Nuvera Biosciences Company Profile

05:34 EDT 22nd September 2018 | BioPortfolio

Nuvera Biosciences is a venture launched in collaboration with The University of Texas M. D. Anderson Cancer Center (MDACC). The Company is focused on developing novel molecular diagnostics that make a significant impact on cancer care by improving detection techniques and treatment selection in cancer.

MDACC has world-renowned capabilities in cancer molecular research, cancer care, and drug trials. It has a significant reach into the cancer patient community and has developed a repository of high-quality tumor samples and database for molecular analyses. Nuvera's collaboration with MDACC helps launch prospective trials for diagnostic validation, state-of-the-art molecular research, and novel tests within their laboratory facilities.

Location

400 West Cummings Park, Suite 5350
Woburn
Massachusetts
01801
United States of America

Contact

Phone: 781-938-3830
Fax: 781-938-3880
Email: info@nuverabio.com


News Articles [670 Associated News Articles listed on BioPortfolio]

Nuvera Marks 8 Years of Enhancing Patient Experience for Specialty Therapeutics

Nuvera Life Science Consulting, a leading advisor on patient-centered experiences for specialty therapeutics, is celebrating eight years of partnering with top U.S. and int...

Nuvera to Share Key Considerations for Commercializing CAR-TCR Therapies at CAR-TCR Summit

Nuvera Life Science Consulting, an expert partner in developing patient-centric experience strategies for specialty therapeutics, will share key factors for manufacturers o...

ASC Biosciences, Inc. announces ad dates for first television commercial

About ASC Biosciences, Inc.ASC Biosciences, Inc. ("ASC" or the "Company") is a development stage biotechnology company with a proprietary adult stem cell platform capable Read more...

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

Apricus Biosciences, Inc.: Apricus Biosciences Announces Proposed Public Offering

SAN DIEGO, March 27, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that ...

Kaskela Law LLC: IMPORTANT SHAREHOLDER DEADLINE ALERT: Solid Biosciences, Inc. - SLDB

RADNOR, PA / ACCESSWIRE / May 23, 2018 / Kaskela Law LLC reminds Solid Biosciences, Inc. (NASDAQ: SLDB) ("Solid Biosciences" or the "Company") investors that a class action complaint has been filed...

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Individual Patient Expanded Access for AB-SA01, an Investigational Anti-Staphylococcus Aureus Bacteriophage Therapeutic

The purpose of the expanded access program is to allow physicians to provide treatment with investigational drug, AB-SA01, for patients with serious or immediately life-threatening Staphyl...

Companies [364 Associated Companies listed on BioPortfolio]

Nuvera Biosciences

Nuvera Biosciences is a venture launched in collaboration with The University of Texas M. D. Anderson Cancer Center (MDACC). The Company is focused on developing novel molecular diagnostics that make ...

Nuvera Life Science Consulting

Nuvera Life Science Consulting helps the world’s leading pharmaceutical and biotech companies deliver impactful patient and HCP support experiences for specialty and rare-dis...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Nuvera Biosciences" on BioPortfolio

We have published hundreds of Nuvera Biosciences news stories on BioPortfolio along with dozens of Nuvera Biosciences Clinical Trials and PubMed Articles about Nuvera Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nuvera Biosciences Companies in our database. You can also find out about relevant Nuvera Biosciences Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...


Corporate Database Quicklinks



Searches Linking to this Company Record